Wave Life Sciences WVE Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Wave Life Sciences's contract liabilities, non-current?
- Wave Life Sciences (WVE) reported contract liabilities, non-current of $14.6M in Q1 2026.
- How has Wave Life Sciences's contract liabilities, non-current changed year-over-year?
- Wave Life Sciences's contract liabilities, non-current increased by 161.4% year-over-year, from $5.58M to $14.6M.
- What is the long-term trend for Wave Life Sciences's contract liabilities, non-current?
- Over 5 years (2020 to 2025), Wave Life Sciences's contract liabilities, non-current has grown at a -28.4% compound annual growth rate (CAGR), from $41.48M to $7.8M.